Get started
Author

Marianne Mancini

Observed names: M Mancini, M. Mancini
OpenAlex ID: A5013813636
LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial
2019 · Rohit Loomba, Joel Neutel, et al. · Journal of Hepatology · 84
Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency
2006 · Joseph A. Church, Heinz Leibl, et al. · Journal of Clinical Immunology · 80
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
2010 · G Serafini, M Pompili, et al. · PubMed · 11
VK2809, a novel liver-directed thyroid receptor agonist, produces durable reductions in liver fat in patients with non-alcoholic fatty liver disease: results of 4-week follow-up assessment from a 12-week phase 2 randomized, placebo-controlled trial
2020 · Brian Lian, Rohit Loomba, et al. · Journal of Hepatology · 9
CO107 Obesity Impact on Incidence of Chronic Comorbid Conditions
2025 · Karen Chung, Marianne Mancini, et al. · Value in Health
PDF
A study to evaluate the safety, tolerability, processing by the body, and response of the body to the drug VK2735 in healthy adults
2021 · Marianne Mancini, Joel Neutel · http://isrctn.com/
P.2.c.008 Assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease
2010 · M. Mancini, G. Meco, et al. · European Neuropsychopharmacology
Efficacy, safety and tolerability of a new intravenous immune globulin, 10% liquid, triple virus reduced (IGIV,10%TVR) in patients with primary immunodeficiency (PID)
2005 · J.A. Church, H. Leibl, et al. · Journal of Allergy and Clinical Immunology
Works count: 8
Citation count: 184
H-index: 4
I10-index: 3
Year
Topic
Type